4
Changes in Ownership
Roivant Sciences Ltd. Filed Acc 0001140361-25-010120
President & COO sold 750,000 shares at an average $10.92 ($8,190,725)
- President & COO acquired 1,002,311 shares (option exercise)
- President & COO gave up 10,945 shares (to pay taxes)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Venker Eric President & COO | 2025-03-20 | Shares withheld for taxes 10b5-1 | −10,945 | $10.97 | $120,067 | 874,979 | D |
| Venker Eric President & COO | 2025-03-20 | Option exercise 10b5-1 | +400,000 | $3.85 | $1,540,000 | 1,274,979 | D |
| Venker Eric President & COO | 2025-03-20 | Sale 10b5-1 | −315,522 | $11.06 | $3,489,673 | 959,457 | D |
| Venker Eric President & COO | 2025-03-24 | Option exercise 10b5-1 | +602,311 | $3.85 | $2,318,897 | 1,561,768 | D |
| Venker Eric President & COO | 2025-03-24 | Sale 10b5-1 | −434,478 | $10.82 | $4,701,052 | 1,127,290 | D |
| Derivatives | |||||||
| Venker Eric President & COO | 2025-03-20 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −400,000 | 10,526,234 | D | ||
| Venker Eric President & COO | 2025-03-24 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −602,311 | 9,923,923 | D | ||
| Open-market sales · 750,000 sh · avg $10.92 · $8,190,725 | |||||||
Loading xslF345X05/form4.xml…